NCT02032732

Brief Summary

Pediatric joint infections are a common diagnostic dilemma encountered by treating orthopaedic surgeons. No single test is sensitive or specific enough to stand alone in determining the presence of joint infection. The purpose of this study is to test the usefulness of a chemical test strip to detect infection in fluid that is removed from a joint (intra-articular aspiration) in pediatric patients. The test strip measures an enzyme called leukocyte esterase, which has been shown to be useful in detecting the presence of infection in fluids from other parts of the body. This study will assess the efficacy of the leukocyte esterase test as a diagnostic tool for evaluating pediatric joint infections. The hypothesis of the study is that a positive leukocyte esterase test identifies a septic joint in pediatric patients undergoing intraoperative joint aspiration.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

December 20, 2013

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 10, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

November 29, 2018

Status Verified

November 1, 2018

Enrollment Period

2 years

First QC Date

December 20, 2013

Last Update Submit

November 27, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • leukocyte esterase level using a leukocyte esterase test strip

    A positive leukocyte esterase test strip will be considered an indicator of a septic joint

    at the time of an intraoperative joint aspiration

Secondary Outcomes (1)

  • baseline leukocyte esterase level for pediatric patients using a leukocyte esterase test strip

    at the time of intraoperative joint aspiration

Study Arms (2)

suspected infection

leukocyte esterase test on fluid removed by intra-articular aspiration for suspected infection

Other: leukocyte esterase test

no suspected infection

leukocyte esterase test on fluid removed by intra-articular aspiration for reason other than suspected infection

Other: leukocyte esterase test

Interventions

leukocyte esterase test on fluid removed by intra-articular aspiration

no suspected infectionsuspected infection

Eligibility Criteria

Age3 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

pediatric patients at a tertiary referral center who will receive an intra-articular aspiration

You may qualify if:

  • All patients at this facility over the age of 3 months and below the age of 18 years who receive an intra-articular aspiration

You may not qualify if:

  • Immunocompromised patients
  • Renal failure patients
  • Patients younger than 3 months old
  • Patients 18 years of age or older
  • Volume of aspirate is less than 1.5 mL

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Orthopaedics, Erlanger Health System

Chattanooga, Tennessee, 37403, United States

Location

MeSH Terms

Conditions

Arthritis, Infectious

Condition Hierarchy (Ancestors)

InfectionsArthritisJoint DiseasesMusculoskeletal Diseases

Study Officials

  • Julie Zielinski, M.D.

    UTCOM Chattanooga/Erlanger Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2013

First Posted

January 10, 2014

Study Start

December 1, 2013

Primary Completion

December 1, 2015

Study Completion

December 1, 2016

Last Updated

November 29, 2018

Record last verified: 2018-11

Locations